25 LLC’s GSK GSK Stock Holding History

25 LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-46	Closed	-$1.6K	–	233
2023 Q2	$1.6K	Hold	46	–	–	﹤0.01%	228
2023 Q1	$1.69K	Buy	+46	New	+$1.61K	﹤0.01%	213

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

25 LLC's GSK Position: Q3 2023 in Review

25 LLC sold out of GSK (GSK) in Q3 2023, closing a stake of 46 shares — an estimated $1.6K sold.

25 LLC first reported a position in GSK in Q1 2023 and held it in 2 quarters. The position peaked at $1.69K in Q1 2023. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

25 LLC reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
25 LLC sold 46 GSK shares in Q3 2023, an estimated $1.6K.
25 LLC first reported a position in GSK in Q1 2023 and held it in 2 quarters.
25 LLC's GSK position peaked at $1.69K in Q1 2023.
846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.